Danaher Co. (NYSE:DHR) Shares Sold by Zacks Investment Management

Zacks Investment Management cut its stake in Danaher Co. (NYSE:DHR) by 0.3% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 74,130 shares of the conglomerate’s stock after selling 203 shares during the period. Zacks Investment Management’s holdings in Danaher were worth $10,595,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in DHR. MBM Wealth Consultants LLC lifted its stake in Danaher by 2.0% during the 2nd quarter. MBM Wealth Consultants LLC now owns 3,701 shares of the conglomerate’s stock valued at $529,000 after acquiring an additional 74 shares during the period. Mechanics Bank Trust Department lifted its stake in Danaher by 1.7% during the 2nd quarter. Mechanics Bank Trust Department now owns 4,384 shares of the conglomerate’s stock valued at $627,000 after acquiring an additional 75 shares during the period. Adirondack Trust Co. lifted its stake in Danaher by 3.1% during the 1st quarter. Adirondack Trust Co. now owns 2,635 shares of the conglomerate’s stock valued at $349,000 after acquiring an additional 78 shares during the period. Cornerstone Advisors Inc. lifted its stake in Danaher by 2.9% during the 1st quarter. Cornerstone Advisors Inc. now owns 2,783 shares of the conglomerate’s stock valued at $367,000 after acquiring an additional 79 shares during the period. Finally, Copperwynd Financial LLC lifted its stake in Danaher by 1.9% during the 2nd quarter. Copperwynd Financial LLC now owns 4,144 shares of the conglomerate’s stock valued at $592,000 after acquiring an additional 79 shares during the period. Institutional investors own 78.43% of the company’s stock.

Several analysts have commented on the stock. Royal Bank of Canada set a $134.00 price objective on shares of Danaher and gave the company a “hold” rating in a research note on Friday, July 19th. Piper Jaffray Companies lifted their price objective on shares of Danaher from $148.00 to $153.00 and gave the company a “neutral” rating in a research note on Thursday, July 18th. Robert W. Baird lifted their price objective on shares of Danaher from $131.00 to $148.00 and gave the company an “outperform” rating in a research note on Friday, July 19th. Wolfe Research assumed coverage on shares of Danaher in a research note on Thursday, May 30th. They set an “outperform” rating for the company. Finally, Needham & Company LLC restated a “buy” rating and set a $155.00 price objective (up from $142.00) on shares of Danaher in a research note on Friday, July 19th. Three analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The stock has an average rating of “Buy” and an average target price of $143.54.



Shares of NYSE:DHR traded down $0.05 during trading on Tuesday, hitting $144.55. 3,057,574 shares of the stock traded hands, compared to its average volume of 2,267,830. The company has a quick ratio of 1.91, a current ratio of 2.32 and a debt-to-equity ratio of 0.33. The company has a market cap of $105.07 billion, a price-to-earnings ratio of 31.98, a P/E/G ratio of 2.64 and a beta of 0.94. The company has a fifty day moving average price of $140.59 and a two-hundred day moving average price of $136.18. Danaher Co. has a 52-week low of $94.59 and a 52-week high of $147.33.

Danaher (NYSE:DHR) last posted its earnings results on Thursday, July 18th. The conglomerate reported $1.19 earnings per share for the quarter, beating the consensus estimate of $1.15 by $0.04. The firm had revenue of $5.16 billion during the quarter, compared to analyst estimates of $5.09 billion. Danaher had a net margin of 12.22% and a return on equity of 11.53%. The business’s quarterly revenue was up 3.5% on a year-over-year basis. During the same period in the previous year, the firm earned $1.15 EPS. On average, equities research analysts predict that Danaher Co. will post 4.79 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Friday, September 27th will be issued a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 0.47%. The ex-dividend date of this dividend is Thursday, September 26th. Danaher’s dividend payout ratio (DPR) is 15.04%.

In other news, Chairman Mitchell P. Rales bought 2,500 shares of the business’s stock in a transaction dated Friday, August 23rd. The stock was purchased at an average cost of $139.52 per share, with a total value of $348,800.00. Following the acquisition, the chairman now directly owns 3,030,453 shares in the company, valued at $422,808,802.56. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Brian W. Ellis sold 1,010 shares of Danaher stock in a transaction that occurred on Friday, July 26th. The shares were sold at an average price of $144.04, for a total transaction of $145,480.40. Following the transaction, the insider now directly owns 20,889 shares of the company’s stock, valued at $3,008,851.56. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 177,202 shares of company stock valued at $25,175,829. Insiders own 11.40% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

See Also: How to interpret Moving Average Convergence Divergence (MACD)

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.